Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
EVP, Chief Medical Officer
-
Stock Symbol
-
NTLA on Nasdaq
David Lebwohl - trading volume in the past year for Intellia Therapeutics, Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
131K |
$1.18M |
$8.99 |
Mar 1, 2025 |
Direct |
|
|
| Restricted Stock Unit |
0 |
$0 |
$19.01 |
Jan 1, 2025 |
Direct |
Common Stock |
|
| Stock Option (right to buy) |
61.7K |
|
|
Mar 1, 2025 |
Direct |
Common Stock |
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.